umbilical cord mesenchymal stem cells + umbilical cord mesenchymal stem cell exosomes

**Umbilical cord mesenchymal stem cells + umbilical cord mesenchymal stem cell exosomes** is a regenerative medicine combination composed of live umbilical cord-derived mesenchymal stem cells together with extracellular vesicles released from those same or similar umbilical cord mesenchymal stem cells. The intended pharmacology is paracrine rather than single-target: the cellular component is expected to provide immunomodulatory, anti-inflammatory, anti-fibrotic, pro-angiogenic, and tissue-repair activity, while the exosome component delivers bioactive proteins, lipids, and RNAs that may reinforce these regenerative signaling pathways. This appears to be a product concept or descriptive combination rather than a clearly established single branded drug, and publicly identifiable evidence is much stronger for the individual components than for a distinct, standardized combined product. Potential use cases in the literature and trial landscape for the constituent modalities include tissue repair, wound healing, inflammatory disorders, and other regenerative indications, but the exact developer, manufacturing process, indication set, and clinical stage for the specific combination are not clearly established from the available evidence.

Other names

human umbilical cord mesenchymal stem cells + human umbilical cord mesenchymal stem cell-derived exosomeshUC-MSCs + hUC-MSC-ExosUCMSCs + UCMSC-Exos